Ossium Health

Undisclosed Clin2 hematologic malignancies; undisclosed Clin1 organ transplant rejection; undisclosed Clin0 GvHD

Ossium Health is treating blood cancers through developing a bone marrow bank. Leukemia and bone cancer patients can be treated with cell therapies to re-educate their immune systems; however, for many, treatments are inaccessible. Ossium is solving this with stem cell science to turn recovered donor tissue into a bone marrow bank to distribute cell therapies on demand to patients at need. To deploy the cell therapies, Ossium works closely with healthcare providers and life science companies. Stem cells for hematologic diseases are already in clinical trials. Ossium is also developing treatment options for organ transplant rejection and diseases of inflammation.